{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-022782","form_type":"8-K","ticker":"DYAI","cik":"0001213809","company_name":"DYADIC INTERNATIONAL INC","filed_at":"2023-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.345808+00:00","generated_at":"2026-06-11T21:31:34.816260+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Dyadic Q2 net loss narrows to $2.15M; positive Phase 1 safety data for COVID booster DYAI-100","bullets":["Net loss $2.15M (-$0.07/sh) vs -$3.29M (-$0.12/sh) YoY; revenue $837K up from $659K.","Positive interim Phase 1 data: no major safety issues, immune response at both low and high doses of DYAI-100.","Cash $10.2M at June 30, 2023, down from $12.7M at Dec 31, 2022.","New fully funded collaborations: Top 5 pharma for vaccine antigen, EDCL in Bangladesh, Fermbox for alternative proteins.","Developed animal-free recombinant serum albumin; structurally equivalent to animal-derived product."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-022782","json":"https://secwatch.observer/filing/0001437749-23-022782.json","markdown":"https://secwatch.observer/filing/0001437749-23-022782.md","text":"https://secwatch.observer/filing/0001437749-23-022782.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213809/000143774923022782/0001437749-23-022782-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213809/000143774923022782/dyai20230531_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T21:31:34.816260+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5cd1edcd7f07d25f6551d636e2c71e4c8b6c08e9","claim":"DYADIC INTERNATIONAL INC reported financial results for the second quarter of 2023.","evidence_excerpt":"On August 9, 2023, Dyadic International, Inc. (\"Dyadic\") issued a press release announcing its results for the quarter ended June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1213809/000143774923022782/0001437749-23-022782-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second quarter of 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}